Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with acute myeloid leukemia

Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are included in the study. In 91 patients (86.7%) hematolog...

Celý popis

Podrobná bibliografie
Hlavní autoři: N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Médium: Článek
Jazyk:Russian
Vydáno: ABV-press 2022-11-01
Edice:Онкогематология
Témata:
children
acute myeloid leukemia
intermediate and unfavorable prognosis
survival
hematopoietic stem cells transplantation
On-line přístup:https://oncohematology.abvpress.ru/ongm/article/view/645

Internet

https://oncohematology.abvpress.ru/ongm/article/view/645

Podobné jednotky